THC
14.2–17.7%
CBD
0.2%
Cassius is a hybrid from Stoney Girl Gardens with 14.2-17.7 percent THC and documented pain and inflammation uses.
No effect, terpene or flavor data specific to Cassius has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
Explore More
THC in this profile
17.7% THC
About Cassius
A name borrowed from Roman history gives this hybrid some gravity, and for once the medical column isn't empty: Cassius is logged with recorded uses for pain and inflammation, two of the more commonly cited reasons people reach for cannabis in the first place. Stoney Girl Gardens offers this version, with lab THC settling between 14.2 and 17.7 percent, a moderate range that fits a plant positioned around those medical entries rather than raw potency. No terpene or flavor data comes with the listing, so there's nothing on record about how it smells or tastes, and no lineage is documented either, leaving its actual genetic background unconfirmed. What stands out here isn't the number so much as the fact that this entry has medical use data at all, something most of its neighbors in this dataset simply don't carry.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Cassius
Is Cassius an Indica, Sativa, or Hybrid?
Cassius is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Cassius?
Cassius: 17.7% THC and 0.2% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.